Cargando…

Peripheral Biomarkers in Manifest and Premanifest Huntington’s Disease

Huntington’s disease (HD) is characterized by clinical motor impairment (e.g., involuntary movements, poor coordination, parkinsonism), cognitive deficits, and psychiatric symptoms. An inhered expansion of the CAG triplet in the huntingtin gene causing a pathogenic gain-of-function of the mutant hun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morena, Emanuele, Romano, Carmela, Marconi, Martina, Diamant, Selene, Buscarinu, Maria Chiara, Bellucci, Gianmarco, Romano, Silvia, Scarabino, Daniela, Salvetti, Marco, Ristori, Giovanni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10094222/ https://www.ncbi.nlm.nih.gov/pubmed/37047023 http://dx.doi.org/10.3390/ijms24076051

Ejemplares similares

Late-Onset MS: Disease Course and Safety-Efficacy of DMTS
por: Buscarinu, Maria Chiara, et al.
Publicado: (2022)

MAIT Cells and Microbiota in Multiple Sclerosis and Other Autoimmune Diseases
por: Mechelli, Rosella, et al.
Publicado: (2021)

Circulating hsa-miR-323b-3p in Huntington's Disease: A Pilot Study
por: Ferraldeschi, Michela, et al.
Publicado: (2021)

Circulating U13 Small Nucleolar RNA as a Potential Biomarker in Huntington’s Disease: A Pilot Study
por: Romano, Silvia, et al.
Publicado: (2022)

Multiple Sclerosis and SARS-CoV-2: Has the Interplay Started?
por: Bellucci, Gianmarco, et al.
Publicado: (2021)

Multiple sclerosis genetic and non-genetic factors interact through the transient transcriptome
por: Umeton, Renato, et al.
Publicado: (2022)

A Case of Double Standard: Sex Differences in Multiple Sclerosis Risk Factors
por: Angeloni, Benedetta, et al.
Publicado: (2021)

Computerised Dynamic Posturography in Premanifest and Manifest individuals with Huntington’s Disease
por: Reyes, Alvaro, et al.
Publicado: (2018)

Visual Object Perception in Premanifest and Early Manifest Huntington’s Disease
por: Coppen, Emma M, et al.
Publicado: (2019)

Time will tell: Decision making in premanifest and manifest Huntington’s disease
por: Heim, Beatrice, et al.
Publicado: (2020)

Revealing the Timeline of Structural MRI Changes in Premanifest to Manifest Huntington Disease
por: Wijeratne, Peter A., et al.
Publicado: (2021)

The Contribution of Gut Barrier Changes to Multiple Sclerosis Pathophysiology
por: Buscarinu, Maria Chiara, et al.
Publicado: (2019)

Magnetization transfer imaging in ‘premanifest’ Huntington’s disease
por: Jurgens, Caroline K., et al.
Publicado: (2009)

Novel Nut and Bolt Task Quantifies Motor Deficits in Premanifest and Manifest Huntington’s Disease
por: Collins, Lucy M., et al.
Publicado: (2015)

Spatiotemporal Gait Parameters in Adults With Premanifest and Manifest Huntington’s Disease: A Systematic Review
por: Browning, Sasha, et al.
Publicado: (2023)

Reworking GWAS Data to Understand the Role of Nongenetic Factors in MS Etiopathogenesis
por: Mechelli, Rosella, et al.
Publicado: (2020)

Sleep deficits but no metabolic deficits in premanifest Huntington's disease
por: Lazar, Alpar S., et al.
Publicado: (2015)

MRI T2 Hypointensities in basal ganglia of premanifest Huntington's disease
por: Jurgens, Caroline K, et al.
Publicado: (2010)

White matter predicts functional connectivity in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

Premanifest Huntington’s disease: Examination of oculomotor abnormalities in clinical practice
por: Winder, Jessica Y., et al.
Publicado: (2018)

Testing a longitudinal compensation model in premanifest Huntington’s disease
por: Gregory, Sarah, et al.
Publicado: (2018)

In vivo characterization of white matter pathology in premanifest huntington's disease
por: Zhang, Jiaying, et al.
Publicado: (2018)

Lumbar puncture safety and tolerability in premanifest and manifest Huntington’s disease: a multi-analysis cross-sectional study
por: Hassan, Yara Refaat, et al.
Publicado: (2022)

Seven-year clinical follow-up of premanifest carriers of Huntington's disease
por: Hart, Ellen, et al.
Publicado: (2011)

Abnormal Electrophysiological Motor Responses in Huntington’s Disease: Evidence of Premanifest Compensation
por: Turner, Lauren M., et al.
Publicado: (2015)

Safer Attitude to Risky Decision-Making in Premanifest Huntington’s Disease Subjects
por: D’Aurizio, Giulia, et al.
Publicado: (2019)

CNS inflammatory demyelinating events after COVID-19 vaccines: A case series and systematic review
por: Rinaldi, Virginia, et al.
Publicado: (2022)

Linking white matter and deep gray matter alterations in premanifest Huntington disease
por: Faria, Andreia V., et al.
Publicado: (2016)

Baseline multimodal information predicts future motor impairment in premanifest Huntington's disease
por: Castro, Eduardo, et al.
Publicado: (2018)

Structural and functional brain network correlates of depressive symptoms in premanifest Huntington's disease
por: McColgan, Peter, et al.
Publicado: (2017)

Timing of selective basal ganglia white matter loss in premanifest Huntington’s disease
por: Zeun, Paul, et al.
Publicado: (2022)

Can leukocyte telomere shortening be a possible biomarker to track Huntington’s disease progression?
por: Mantuano, Elide, et al.
Publicado: (2019)

Evaluation of longitudinal 12 and 24 month cognitive outcomes in premanifest and early Huntington's disease
por: Stout, Julie C, et al.
Publicado: (2012)

Body composition in premanifest Huntington’s disease reveals lower bone density compared to controls.
por: Goodman, Anna O. G., et al.
Publicado: (2011)

Topological length of white matter connections predicts their rate of atrophy in premanifest Huntington’s disease
por: McColgan, Peter, et al.
Publicado: (2017)

Resting-state connectivity stratifies premanifest Huntington’s disease by longitudinal cognitive decline rate
por: Polosecki, Pablo, et al.
Publicado: (2020)

The effect of impulsivity and inhibitory control deficits in the saccadic behavior of premanifest Huntington’s disease individuals
por: Júlio, Filipa, et al.
Publicado: (2019)

Hair and salivary cortisol and their relationship with lifestyle, mood and cognitive outcomes in premanifest Huntington’s disease
por: Cruickshank, Travis, et al.
Publicado: (2021)

The relationship between non-motor features and weight-loss in the premanifest stage of Huntington’s disease
por: Khan, Wasiq, et al.
Publicado: (2021)

SARS-CoV-2 meta-interactome suggests disease-specific, autoimmune pathophysiologies and therapeutic targets
por: Bellucci, Gianmarco, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_371sk0922otntnchhfpdejng15